Myocardial infarct size reduction by the synergistic effect of hyperbaric oxygen and recombinant tissue plasminogen activator

American Heart Journal
M P ThomasD P Guyton

Abstract

Fasting mongrel dogs underwent hyperbaric oxygen treatment (HBOT), recombinant tissue plasminogen activator (rt-PA) treatment, and simultaneous HBOT and rt-PA treatment following prior experimental left anterior descending coronary artery occlusion for 2 hours. Thrombosis in and around a copper coil was recorded angiographically at regular intervals, and immediately prior to treatment conclusion. Controls (n = 10) were untreated. Group two animals (n = 10) were treated additionally with 90 minutes of HBOT at 2 atm absolute. Group three animals (n = 8) were treated additionally with 50 mg rt-PA over 90 minutes. Group four animals (n = 10) were treated additionally with simultaneous HBOT and rt-PA over 90 minutes. Myocardial injury was determined by a combination of triphenyltetrazolium chloride histochemical staining and by formazan dye extraction. Damage was measured as a percent of left ventricular cross-sectional area studied. HBOT alone restored 35.9% of oxidative enzyme activity (p greater than 0.001). Treatment with rt-PA alone restored 48.9% of enzyme activity (p greater than 0.001). The combination of HBOT and simultaneous rt-PA resulted in 96.9% restoration of oxidative enzyme activity versus the control group (p greate...Continue Reading

References

Oct 1, 1989·Journal of the American College of Cardiology·N U BangM D Clayman
Jan 1, 1989·American Heart Journal·S R DevriesD R Abendschein
Nov 1, 1973·Annals of Internal Medicine·P R Maroko, E Braunwald
May 1, 1968·Progress in Cardiovascular Diseases·R E Whalen, H A Saltzman
Dec 1, 1981·Annals of Internal Medicine·R E RudeE Braunwald
Dec 1, 1982·Circulation·E Braunwald, R A Kloner
Mar 1, 1982·The Journal of Clinical Investigation·C KorningerD Collen

❮ Previous
Next ❯

Citations

Oct 20, 2006·Advances in Therapy·Jeysen Zivan YogaratnamSteve Griffin
Aug 14, 2009·Clinical and Experimental Pharmacology & Physiology·Leonardo dos SantosPaulo J F Tucci
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Antonio L Bartorelli
Jan 26, 2011·Cell Biochemistry and Function·Leigh A MaddenGerard Laden
Nov 1, 1992·The American Journal of Emergency Medicine·L D Weiss, K W Van Meter
Aug 2, 2008·Pediatric Transplantation·Benan Bayrakci
May 3, 2005·Journal of the American College of Cardiology·Daniel SatranTimothy D Henry
Dec 3, 2016·Expert Review of Respiratory Medicine·Jonathan A GehlbachIra M Cheifetz
Dec 6, 2003·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·J Richard SpearsRichard vander Heide
Feb 13, 2014·American Journal of Therapeutics·Jalaj GargWilliam H Frishman
Jun 26, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Lynne L JohnsonDavid O Williams
May 15, 2018·Journal of the American Animal Hospital Association·Gemma L BirnieMatthew P Best
Mar 21, 2000·International Anesthesiology Clinics·J Buras
May 2, 2006·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Daniela TrabattoniWilliam W O'Neill
Sep 14, 2006·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·David G RizikSimon R Dixon
Nov 16, 2019·Cardiovascular Toxicology·Chien-Cheng HuangHow-Ran Guo
Jul 24, 2015·The Cochrane Database of Systematic Reviews·Michael H BennettNigel Jepson
Mar 1, 1997·The American Journal of Physiology·S R ThomL Kilpatrick
Aug 12, 2010·Acute Cardiac Care·Giampaolo NiccoliFilippo Crea
Aug 19, 1999·The Journal of Trauma·R L Sheridan, E S Shank
Sep 14, 2018·Frontiers in Cardiovascular Medicine·Anjali M PrabhatPeriannan Kuppusamy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.